0001104659-23-002591.txt : 20230110
0001104659-23-002591.hdr.sgml : 20230110
20230110122604
ACCESSION NUMBER: 0001104659-23-002591
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
FILED AS OF DATE: 20230110
DATE AS OF CHANGE: 20230110
EFFECTIVENESS DATE: 20230110
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apogee Health, LP
CENTRAL INDEX KEY: 0001961542
IRS NUMBER: 921320505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-470190
FILM NUMBER: 23520391
BUSINESS ADDRESS:
STREET 1: 139 S. LINWOOD AVENUE
CITY: BALTIMORE
STATE: MD
ZIP: 21224
BUSINESS PHONE: (321) 987-6522
MAIL ADDRESS:
STREET 1: 139 S. LINWOOD AVENUE
CITY: BALTIMORE
STATE: MD
ZIP: 21224
D
1
primary_doc.xml
X0708
D
LIVE
0001961542
Apogee Health, LP
139 S. LINWOOD AVENUE
BALTIMORE
MD
MARYLAND
21224
(321) 987-6522
DELAWARE
None
None
Limited Partnership
true
2022
N/A
Sherpa Partners, Inc.
139 S. Linwood Avenue
Baltimore
MD
MARYLAND
21224
Executive Officer
Promoter
General Partner of Issuer
Michael
Batista
c/o Sherpa Partners, Inc.
139 S. Linwood Avenue
Baltimore
MD
MARYLAND
21224
Executive Officer
Director
Chair and Director of General Partner of Issuer
Doba
Parushev
c/o Sherpa Partners, Inc.
139 S. Linwood Avenue
Baltimore
MD
MARYLAND
21224
Director
Director of General Partner of Issuer
Dessy
Levinson
c/o Sherpa Partners, Inc.
139 S. Linwood Avenue
Baltimore
MD
MARYLAND
21224
Director
Director of General Partner of Issuer
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
false
2023-01-05
false
true
true
false
0
Indefinite
31320000
Indefinite
false
2
0
0
0
true
Customary management fees and carried interest are paid by Issuer to General Partner and an Affiliate, respectively, as provided in offering materials. Amount indeterminate at this time.
false
Apogee Health, LP
/s/ Michael Batista
Michael Batista
Chair of General Partner of Issuer
2023-01-10